Variable | Cases (relapse) N = 31 | Controls (non-relapse) N = 128 | Univariate model | Multivariate model | |||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P | OR | 95% CI | P | ||||
Age, mean (SD) | 52.0 (17.0) | 60.5 (18.6) | 0.98 | 0.95-1.00 | 0.02* | ||||
Sex | Female | 16 (51.6%) | 49 (38.3%) | female as reference | |||||
Male | 15 (48.4%) | 79 (61.7%) | 0.58 | 0.26-1.28 | 0.18 | ||||
Medical Service | Med/surg | 10 (32.3%) | 82 (64.1%) | general medical / surgical as reference | |||||
Haem/onc | 15 (48.4%) | 30 (23.4%) | 4.1 | 1.66-10.11 | 0.002* | ||||
Renal | 6 (19.4%) | 16 (12.5%) | 3.08 | 0.98-9.66 | 0.06 | ||||
Definitive therapy | Standard | 23 (74.2%) | 105 (82.0%) | carbapenem, quinolone, cefepime, aminoglycoside or co-trimoxazole as reference | |||||
BLBLI | 6 (19.4%) | 15 (11.7%) | 1.83 | 0.64-5.21 | 0.26 | ||||
Inappropriate | 2 (6.5%) | 8 (6.2%) | 1.14 | 0.23-5.73 | 0.87 | ||||
Source | Non-line source | 8 (25.8%) | 80 (62.5%) | non-line source as reference | |||||
Line-associated | 23 (74.2%) | 48 (37.5%) | 4.79 | 1.99-11.56 | <0.001* | 3.87 | 1.56-9.60 | 0.004* | |
Immune suppression | Absent | 12 (38.7%) | 83 (64.8%) | no immunosuppression as reference | |||||
Present | 19 (61.3%) | 45 (35.2%) | 2.92 | 1.30-6.56 | 0.009* | 2.70 | 1.14-6.44 | 0.02* | |
ICU admission | Non-ICU | 25 (80.6%) | 99 (78.6%) | non-ICU admitted as reference | |||||
ICU | 6 (19.4%) | 27 (21.4%) | 0.88 | 0.33-2.36 | 0.80 | ||||
Acquisition status | Community | 2 (6.5%) | 29 (22.7%) | community-associated infection as reference | |||||
Healthcare | 29 (93.5%) | 99 (77.3%) | 4.25 | 0.96-18.87 | 0.06 | ||||
Region | NSW | 15 (48.4%) | 73 (57.0%) | New South Wales region as reference | |||||
Queensland | 16 (51.6%) | 55 (43.0%) | 1.42 | 0.64-3.11 | 0.39 | ||||
De-repressed AmpC phenotype | Absent | 22 (71.0%) | 76 (59.4%) | no de-repressed AmpC as reference | |||||
Present | 9 (29.0%) | 52 (40.6%) | 0.60 | 0.26-1.40 | 0.24 | ||||
SAPS II score, mean (SD) | 37.9 (15.9) | 33.9 (12.9) | 1.02 | 0.99-1.05 | 0.14 | ||||
Enterobacter species | Other Enterobacter spp. | 6 (19.4%) | 31 (24.2%) | other Enterobacter spp. as reference | |||||
E. cloacae | 25 (80.6%) | 97 (75.8%) | 1.33 | 0.50-3.54 | 0.57 |